Investigational Antibiotic Noninferior To Dual Therapy For Treatment Of Uncomplicated Urogenital Gonorrhea, Late-Stage Results Show

MedPage Today (4/30, Kahn) reports investigational antibiotic gepotidacin “proved noninferior to dual therapy for the treatment of uncomplicated urogenital gonorrhea, according to results of the phase III EAGLE-1 trial.” Results presented during the European Society of Clinical Microbiology and Infectious Diseases Global Congress show “the microbiological success rate was 92.6% with oral gepotidacin compared with 91.2% with ceftriaxone plus oral azithromycin.”